Amedisys (AMED) Tops Q1 EPS by 11c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.00, $0.11 better than the analyst estimate of $0.89. Revenue for the quarter came in at $556.4 million versus the consensus estimate of $558.81 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Anthropic delays planned IPO from October to November - WSJ
- Corpay agrees to $100M FTC settlement over marketing practices
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
